Free Trial

Charles Schwab Investment Management Inc. Has $116.44 Million Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background
Remove Ads

Charles Schwab Investment Management Inc. increased its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 2.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 400,080 shares of the company's stock after purchasing an additional 10,002 shares during the period. Charles Schwab Investment Management Inc. owned about 0.70% of Molina Healthcare worth $116,443,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of MOH. Los Angeles Capital Management LLC boosted its stake in Molina Healthcare by 166.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company's stock worth $57,195,000 after buying an additional 122,674 shares in the last quarter. Proficio Capital Partners LLC bought a new position in shares of Molina Healthcare during the 4th quarter worth about $26,091,000. NFJ Investment Group LLC acquired a new stake in shares of Molina Healthcare during the 3rd quarter valued at about $7,432,000. Ieq Capital LLC increased its stake in Molina Healthcare by 762.7% in the fourth quarter. Ieq Capital LLC now owns 21,489 shares of the company's stock valued at $6,254,000 after acquiring an additional 18,998 shares during the period. Finally, KBC Group NV raised its position in Molina Healthcare by 14.6% in the fourth quarter. KBC Group NV now owns 125,486 shares of the company's stock worth $36,522,000 after purchasing an additional 15,993 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.11% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

A number of brokerages have commented on MOH. JPMorgan Chase & Co. restated a "neutral" rating and set a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Mizuho cut their target price on Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Truist Financial lowered their price target on Molina Healthcare from $370.00 to $340.00 and set a "buy" rating on the stock in a research report on Wednesday, February 19th. Stephens reiterated an "equal weight" rating and set a $345.00 price objective on shares of Molina Healthcare in a research note on Thursday, February 6th. Finally, Barclays reduced their target price on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research note on Friday, February 7th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $355.69.

Read Our Latest Stock Report on Molina Healthcare

Molina Healthcare Trading Down 3.0 %

MOH traded down $9.78 during trading on Wednesday, reaching $315.03. 565,760 shares of the company's stock were exchanged, compared to its average volume of 768,743. The company's fifty day moving average price is $296.83 and its 200-day moving average price is $311.18. The firm has a market capitalization of $17.48 billion, a PE ratio of 15.42, a P/E/G ratio of 1.06 and a beta of 0.56. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $423.92. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, equities analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Further Reading

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads